Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Current Opinion in Cardiology|May 9, 2012
What is the optimal antithrombotic strategy in primary percutaneous coronary intervention?Ziad Sergie, Roxana Mehran, Gregg W StoneCurrent Opinion in Cardiology|October 4, 2012
Impact of in-hospital major bleeding on outcomes in acute coronary syndromesSharon S Choi, Ziad Sergie, Roxana MehranAmerican Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 3, 2018
Recurrence of eosinophilic granulomatosis with polyangitis after orthotopic heart transplantUjjwal Rastogi, Ziad Sergie, Sean Pinney, et al.Interventional Cardiology Clinics|June 6, 2017
The Use of Bivalirudin in ST-Segment Elevation Myocardial Infarction: Advantages and LimitationsZiad Sergie, Nilusha Gukathasan, Jennifer J Yu, et al.Current Cardiology Reports|May 29, 2012
Is there attenuation of benefit of invasive therapy in patients with chronic kidney disease? Results from randomized trials and registry dataJennifer Yu, Sze-Yuan Ooi, Ziad Sergie, et al.Journal of Vascular and Interventional Radiology : JVIR|June 21, 2003
Closure of a ureterocutaneous fistula with a covered stent-graftDindi D Reddy, Riad Salem, Jose A Gonzalez, et al.Circulation|April 6, 2011
Meta-analysis: impact of drug class on adherence to antihypertensivesIan M Kronish, Mark Woodward, Ziad Sergie, et al.AIDS Patient Care and Stds|May 27, 2005
A model to provide comprehensive testing for HIV, viral hepatitis, and sexually transmitted infections at a short-term drug treatment centerMichelle A Lally, Ryan MacNevin, Ziad Sergie, et al.Journal of Thrombosis and Thrombolysis|April 5, 2013
Current periprocedural anticoagulation in transcatheter aortic valve replacement: could bivalirudin be an option? Rationale and design of the BRAVO 2/3 studiesZiad Sergie, Thierry Lefèvre, Eric Van Belle, et al.Journal of Vascular and Interventional Radiology : JVIR|December 24, 2005
Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TheraSphere): safety, tumor response, and survivalRiad Salem, Robert J Lewandowski, Bassel Atassi, et al.Pageof 2